正在加载视频...

视频加载失败

Introducing a small portion of proprietary phenomics data from Recursion into the training of MolGPS, our foundation model for molecular property prediction, led to massive performance increases on new & existing benchmarks. Learn more about the impact of data & scale.

10,091 次观看 • 1 年前 •via X (Twitter)

4 条评论

Valence Labs 的头像
Valence Labs1 年前

Positive effects were apparent in our initial experiments with the 1B parameter version of MolGPS. The inclusion of @RecursionPharma's data led to an improvement equivalent to scaling the model by a factor of 50. Read the paper for more details:

Valence Labs 的头像
Valence Labs1 年前

Further scaling of the model to 3B parameters led to continued performance gains on ADME and protein binding tasks in @Polaris_HQ, a new benchmarking platform for drug discovery. Explore the results here:

Squeeze Kid 的头像
Squeeze Kid1 年前

@RecursionPharma $RXRX

Squeeze Kid 的头像
Squeeze Kid1 年前

@RecursionPharma @afterhourbot hunt great video to understand what $RXRX does

相关视频